The metabolic hypothesis is more likely than the epileptogenic hypothesis to explain stroke-like lesions

Josef Finsterer1

  • 1Krankenanstalt Rudolfstiftung, Messerli Institute, Vienna, 1180, Austria.

Insights

Stroke-like episodes (SLEs) in mitochondrial disorders are debated. The metabolic hypothesis, supported by imaging and treatment responses, is favored over the epileptogenic hypothesis for understanding stroke-like lesions (SLLs).

Area of Science:

  • Neurology
  • Mitochondrial Diseases
  • Neuroimaging

Background:

  • Stroke-like episodes (SLEs) are characteristic of MELAS syndrome and other mitochondrial disorders (MIDs).
  • The underlying pathophysiology of stroke-like lesions (SLLs) observed in MRI remains debated, with metabolic, epileptogenic, and vascular hypotheses proposed.
  • A recent Delphi consensus favored the epileptogenic hypothesis, recommending antiepileptic drug (ASD) treatment regardless of seizure activity.

Purpose of the Study:

  • To critically evaluate the epileptogenic hypothesis for SLLs in MIDs.
  • To present arguments supporting the metabolic hypothesis for SLL pathogenesis.
  • To advocate for a more targeted approach to ASD use in SLEs.

Main Methods:

  • Review and critique of existing literature and hypotheses regarding SLLs.
  • Analysis of clinical observations and imaging findings (MRI, FDG-PET).
  • Evaluation of treatment responses to various interventions.

Main Results:

  • Arguments against the epileptogenic hypothesis include the frequent absence of seizures or epileptiform discharges, SLLs outside the cortex, limited efficacy of ASDs, and lack of supporting animal models.
  • Evidence supporting the metabolic hypothesis includes SLLs not being confined to vascular territories, reduced oxygen extraction, and hypometabolism on FDG-PET.
  • SLLs have shown positive responses to antioxidants, NO-precursors, steroids, and ketogenic diets.

Conclusions:

  • The epileptogenic hypothesis does not fully explain SLLs in MIDs.
  • The metabolic hypothesis offers a more comprehensive explanation for SLLs.
  • ASDs should be reserved for cases with clear clinical or electrophysiological evidence of seizure activity.